Physician profile
Ronak Patel
NPI 1649405424
$3,132.27
in general payments reported to CMS, 2019-2025
19 companies · $948 in 2025
The $948 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $146 · 2021: $285 · 2022: $145 · 2023: $370 · 2024: $404 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $551.65 | 2019-2022 | |
| Abbott Laboratories | $535.78 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.54 | 2019-2024 | Jardiance |
| Medtronic, INC. | $286.02 | 2025 | Corevalve Evolut R, Symplicity G3 |
| Impulse Dynamics (USA) INC. | $270.59 | 2021 | |
| Inari Medical, INC. | $177.01 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $175.54 | 2019-2024 | |
| Scpharmaceuticals INC. | $151.64 | 2025 | |
| Abiomed | $135.00 | 2024-2025 | Impella |
| Pfizer INC. | $134.83 | 2019-2025 | |
| Atricure, INC. | $129.39 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Medtronic Vascular, INC. | $118.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $24.45 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $17.22 | 2025 | |
| Irhythm Technologies, INC. | $15.96 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $15.41 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $14.72 | 2023 | Verquvo |
| Vifor Pharma, INC. | $13.57 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.